Loffredo John T, Sidney John, Bean Alex T, Beal Dominic R, Bardet Wilfried, Wahl Angela, Hawkins Oriana E, Piaskowski Shari, Wilson Nancy A, Hildebrand William H, Watkins David I, Sette Alessandro
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53706, USA.
J Immunol. 2009 Jun 15;182(12):7763-75. doi: 10.4049/jimmunol.0900111.
HLA-B27- and -B57-positive HIV-infected humans have long been associated with control of HIV replication, implying that CD8(+) T cell responses contribute to control of viral replication. In a similar fashion, 50% of Mamu-B08-positive Indian rhesus macaques control SIVmac239 replication and become elite controllers with chronic-phase viremia <1000 viral RNA copies/ml. Interestingly, Mamu-B08-restricted SIV-derived epitopes appeared to match the peptide binding profile for HLA-B2705 in humans. We therefore defined a detailed peptide-binding motif for Mamu-B08 and investigated binding similarities between the macaque and human MHC class I molecules. Analysis of a panel of approximately 900 peptides revealed that despite substantial sequence differences between Mamu-B08 and HLA-B2705, the peptide-binding repertoires of these two MHC class I molecules share a remarkable degree of overlap. Detailed knowledge of the Mamu-B08 peptide-binding motif enabled us to identify six additional novel Mamu-B08-restricted SIV-specific CD8(+) T cell immune responses directed against epitopes in Gag, Vpr, and Env. All 13 Mamu-B08-restricted epitopes contain an R at the position 2 primary anchor and 10 also possess either R or K at the N terminus. Such dibasic peptides are less prone to cellular degradation. This work highlights the relevance of the Mamu-B08-positive SIV-infected Indian rhesus macaque as a model to examine elite control of immunodeficiency virus replication. The remarkable similarity of the peptide-binding motifs and repertoires for Mamu-B08 and HLA-B2705 suggests that the nature of the peptide bound by the MHC class I molecule may play an important role in control of immunodeficiency virus replication.
长期以来,HLA - B27和 - B57阳性的HIV感染者一直与HIV复制的控制相关,这意味着CD8(+) T细胞反应有助于控制病毒复制。同样,50%的Mamu - B08阳性印度恒河猴可控制SIVmac239复制,并成为慢性期病毒血症<1000病毒RNA拷贝/毫升的精英控制者。有趣的是,Mamu - B08限制性SIV衍生表位似乎与人类HLA - B2705的肽结合谱相匹配。因此,我们定义了Mamu - B08的详细肽结合基序,并研究了猕猴和人类MHC I类分子之间的结合相似性。对一组约900种肽的分析表明,尽管Mamu - B08和HLA - B2705之间存在大量序列差异,但这两种MHC I类分子的肽结合库有显著程度的重叠。对Mamu - B08肽结合基序的详细了解使我们能够识别另外六种针对Gag、Vpr和Env中表位的新型Mamu - B08限制性SIV特异性CD8(+) T细胞免疫反应。所有13个Mamu - B08限制性表位在第2位主要锚定位置含有一个R,并且10个在N端也具有R或K。这种双碱性肽不易被细胞降解。这项工作突出了Mamu - B08阳性SIV感染的印度恒河猴作为研究免疫缺陷病毒复制的精英控制模型的相关性。Mamu - B08和HLA - B2705的肽结合基序和库的显著相似性表明,MHC I类分子结合的肽的性质可能在免疫缺陷病毒复制的控制中起重要作用。